- Introduction: the facts
- The biotechnology industry
and venture capital
- Europe falls behind
- Why does Europe do so poorly?
Some inadequate explanations
- Under-investment in European
Biotechnology
- Public markets and under-investment
- VC management of companies
- VC effects on business efficacy
- Investor blocade of business
- Pomp and circumstance
- The real VC business model
- What to do about it: government
- What to do about it: business
- References
|